Used in cancer immunotherapy research to block the SIRPα-CD47 interaction, enhancing macrophage-mediated phagocytosis of tumor cells. Investigated for potential in treating solid tumors and hematologic malignancies by promoting immune system recognition and destruction of cancer cells. Also utilized as a reference standard in antibody development and bioassay calibration.